Banking heavily on APACHE III

Banking heavily on APACHE III

By Karen Bernstein Editor-in-ChiefThe physician who devised the modified APACHE III method of prospectively defining patients who will benefit from sepsis drugs hopes that the system will become the "common language" of sepsis trials, permitting comparison of future trials and allowing clinicians to consider the efficacy of cocktails of drugs...